Ensysce Biosciences Inc (ENSC) Financials

$0.46

$0.02 (3.57%)

As on 04-Sep-2026 20:00EDT

Market cap

$9 Mln

Revenue (TTM)

$5 Mln

P/E Ratio

--

P/B Ratio

0.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	4.50	5.07	5.21	2.23	2.52	3.53
Cost of Revenue	2.96	10.38	7.22	7.59	19.84	0.00
Gross Profit	-0.34	-5.31	-2.01	-5.36	-17.31	3.53
Operating Expenses	13.83	10.24	6.73	10.72	24.22	19.87
Operating Profit (EBIT)	-12.66	-10.24	-6.73	-10.72	-24.22	-19.87
Other Income	--	--	--	--	--	--
Profit before Tax	-12.62	-10.18	-7.99	-10.63	-24.21	-29.15
Provision for Tax	--	--	--	0.00	0.75	0.00
Profit after Tax (Net Income)	-12.62	-10.18	-7.99	-10.61	-24.96	-29.15
Minority Interest	0.00	0.00	0.00	0.00	0.04	0.06
Consolidated Profit	-6.50	-10.18	-7.99	-10.63	-25.09	-29.89

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	-0.78	3.21	3.71	-0.32	-4.03	-8.16
Minority Interest	0.00	--	--	--	--	--
Non-Current Liabilities	--	--	0.01	0.03	0.45	8.09
Current Liabilities	4.07	4.57	2.21	3.33	9.46	16.48
Total Liabilities	7.03	7.45	5.60	2.71	5.89	16.42

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	0.11	0.21	0.25	0.42	0.59	0.75
Current Assets	2.85	7.24	5.34	2.29	5.30	15.66
Total Assets	7.03	7.45	5.60	2.71	5.89	16.42
Total Debt*	0.20	0.31	0.30	0.85	4.41	17.19
Net Current Assets	-1.22	2.67	3.14	-1.04	-4.17	-0.82

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-7.81	-7.50	-10.78	-17.89	-8.24
Cash Flow from Investing Activities	--	-0.12	--	--	0.00	--
Cash from Financing Activities	--	8.74	9.88	8.76	8.77	20.31
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-2.12	-0.40	-6.50	-4.69	-82.33	-290.30
Cash EPS ($)	--	-0.40	-6.50	-4.69	-82.33	-290.29
Adjusted Book Value ($)	--	0.13	3.02	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.31	-6.10	-4.76	-59.00	-82.09
Free Cash Flow per Share ($)	--	-0.31	-6.10	-4.76	-59.00	-82.09

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-270.25	-351.70	-2,335.25	-530.64	-784.07
ROE (%)	--	-294.00	-471.82	487.68	409.62	393.42
ROA (%)	-167.06	-155.95	-192.33	-247.01	-223.85	-347.61
EBIT Margin (%)	-223.17	-200.48	-129.17	-480.41	-959.91	-562.71
Net Margin (%)	-280.48	-200.84	-153.30	-475.71	-989.21	-825.38
Cash Profit Margin (%)	-0.02	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-39.29	-0.03	1.34	-0.12	-0.29	-0.10
EBIT Growth (%)	27.61	-50.93	37.21	55.75	-21.90	-1,131.67
Net Profit Growth (%)	-91.80	-27.40	24.74	57.48	14.36	-51,440.06
EPS Growth (%)	55.17	0.94	-0.39	0.94	0.72	-32,563.68
Book Value Growth (%)	-103.90	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-2.31	-1.25	-0.23	-0.01	-0.02
Price / Book Value	0.86	7.32	2.70	-7.43	-0.06	-0.06
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.50	-1.92	522,964.64	-0.21	-0.06	-0.27
Close Price ($)	0.29	0.92	8.14	15.90	135.00	16,920.00
High Price ($)	2.75	9.57	30.90	275.40	18,216.00	86,364.00
Low Price ($)	0.23	0.86	2.12	11.48	106.22	4,500.00
Market Cap ($ Cr)	8.87	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.10	0.08	-2.65	-1.09	-2.11
Short term debt to equity ratio	-0.25	0.10	0.08	-2.65	-1.06	-1.56
Current Ratio	0.70	1.59	2.42	0.69	0.56	0.95
Quick Ratio	0.70	--	--	0.85	0.59	0.98
Interest Coverage	-788.32	-541.24	-5.22	-30.28	-221.16	-15.34

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	9.26	8.30	2.38	4.37	10.97	12.51
Asset Turnover	0.60	0.78	1.25	0.52	0.23	0.42
Receivable days	--	19.62	7.77	30.65	52.00	45.69
Inventory Days	--	--	-27.09	-19.55	-6.62	-1,068,467.52
Payable days	--	81.39	83.31	117.46	29.88	2,449,959.12
Cash Conversion Cycle	--	--	-102.63	-106.37	15.51	-3,518,380.95

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.